Skip to main content
Kent Academic Repository

On cost effectiveness analysis and fairness: Normalizing control of and resistance to NICE technology appraisals

Chang, Li-cheng (2020) On cost effectiveness analysis and fairness: Normalizing control of and resistance to NICE technology appraisals. Financial Accountability & Management, . ISSN 0267-4424. E-ISSN 1468-0408. (doi:10.1111/faam.12235) (KAR id:81456)

Abstract

This study examines NICE’s application of cost effectiveness analysis (CEA) for normalizing patients’ access to newly licensed health technologies. Drawing upon evidence from the appraisal of four drugs developed for a rare form of cancer, this study demonstrates that the discourse of CEA provided a medium whereby contradicting ideologies of fairness were contested and resistance was provoked. Far from being docile the patients whom the NICE technology appraisal sought to administer were actively challenging the legitimacy of the calculation of CEA. The patients’ recalcitrance not only undermined the normalizing force but also compelled NICE to revise its application of CEA to suit their own interests. This study concludes that the discursive characteristic of calculating technologies not only constituted but was also constituted by conflicting interests and power struggles.

Item Type: Article
DOI/Identification number: 10.1111/faam.12235
Uncontrolled keywords: NICE, cost effectiveness analysis, fairness, resistance
Subjects: H Social Sciences > HJ Public Finance
Divisions: Divisions > Kent Business School - Division > Department of Accounting and Finance
Depositing User: Li-cheng Chang
Date Deposited: 29 May 2020 20:39 UTC
Last Modified: 05 Nov 2024 12:47 UTC
Resource URI: https://kar.kent.ac.uk/id/eprint/81456 (The current URI for this page, for reference purposes)

University of Kent Author Information

  • Depositors only (login required):

Total unique views for this document in KAR since July 2020. For more details click on the image.